MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Galecto Biotech, Inc. (Nasdaq: GLTO)
Finance & Acquisitions: Galecto Biotech
Parents
Galecto Biotech, Inc. (Nasdaq: GLTO)
Children
2020: Eir Ventures, joined Soleus Capital in leading the D round. Cormorant Asset Management, Janus Henderson Investors, Hadean Capital, Sphera, Asymmetry Capital Management, Canica as new investors.
2020: Galecto Finalizes Plan For $85 Million IPO
2020: Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure and SEED Capital.
2020: Galecto reaps $64M to bring lead drug across IPF finish line, while making moves in NASH and beyond
2020: Not two weeks after closing a Series D round, Galecto files for $100M IPO
PharmAkea
Jumps
Key People: Galecto Biotech
Organization & Developments: Galecto Biotech